Advertisement
Home »

Does the Prognostic Value of Serum Neurofilament Light Chain for Relapsing MS Vary by BMI & Age?

Apr 29, 2024

REFERENCES & ADDITIONAL READING

  1. Cross A, et al. Prognostic value of serum neurofilament light chain for disease activity in patients with relapsing multiple sclerosis: results from subgroup analysis based on body mass index and age from the phase 3 ASCLEPIOS I/II trials. Abstract presented at: ACTRIMS Forum 2024; February 29-March 2, 2024; West Palm Beach, Florida.
  2. Ziemssen T, et al. Prognostic value of serum neurofilament light chain for disease activity and worsening in patients with relapsing multiple sclerosis: results from the phase 3 ASCLEPIOS I and II trials. Front Immunol. 2022;13:852563. doi:10.3389/fimmu.2022.852563

ABOUT THE EXPERTS

  • Anne H. Cross, MD

    Photo Credit: Washington University Physicians

    Professor of Neurology
    Manny and Rosalyn Rosenthal – Dr. John Trotter MS Chair in Neuroimmunology
    Washington University

     

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


EXPLORE MORE

Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement